特定のアポプトティック刺激から血管を保護するRAFの役割
Alireza Alavi1, John D Hood, Ricardo Frausto
1Department of Immunology, Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
まとめ
基礎線維芽細胞成長因子と血管内皮成長因子は,Raf-1を異なる経路で活性化させ,血管新生中にアポトーシスに影響を与えることによって,内皮細胞生存を差異的に調節します.
科学分野:
- 分子生物学は分子生物学である.
- 細胞生物学 細胞生物学
- 血管新生研究の研究
背景:
- ラフキナーゼは,内皮細胞の生存に関与しています.
- 基礎線維細胞成長因子 (bFGF) と血管内皮成長因子 (VEGF) は,血管新生の重要な調節因子である.
研究 の 目的:
- bFGFとVEGFによるRaf-1の異なる活性化を調査する.
- これらの成長因子が内皮細胞の生存を促進し,アポトーシスを抑制する明確な経路を解明する.
主な方法:
- bFGFとVEGFによるRaf-1活性化をヒト内皮細胞とチキの胚血管系で調査した.
- タンパク質のリン酸化 (例えば,PAK-1,Srcキナーゼ) と細胞下局所化 (ミトコンドリアの転位) を分析するテクニックを使用した.
- 保護効果を媒介するミトゲン活性化タンパク質キナーゼキナーゼ-1 (MEK1) の役割を評価した.
主要な成果:
- bFGFは,p21活性化タンパク質キナーゼ-1 (PAK-1) のリン酸化によってRaf-1を活性化させ,ミトコンドリアの転位とMEK1.1から独立して,内在のアポトーシスからの保護につながります.
- VEGFはSrcキナーゼ経由でRaf-1を活性化させ,チロシンリン酸化を引き起こし,MEK1に依存した外来アポトーシスからの保護をもたらした.
- bFGFとVEGFによるRaf-1活性化の明確なメカニズムが実証されています.
結論:
- Raf-1は,血管新生過程における内皮細胞生存の重要な調節体として作用する.
- 成長因子によるRaf-1の異なる活性化は,特定のアポプトシス経路に対する保護を媒介する.
- これらの経路を理解することは,血管新生を標的とした治療戦略にとって不可欠です.
関連する概念動画
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Vascular Spasm
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Autoregulation of Blood Flow
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.


